Vivek Bhalla, MD, Stanford, calls for greater awareness and implementation of existing screening guidelines to help identify patients who may benefit from more targeted, disease-specific interventions ...

Evidence continues to mount regarding the effectiveness of treating primary aldosteronism (PA), with a major international ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Yet screening ...

CHICAGO -- One in 12 patients with incident hypertension screened positive for primary aldosteronism, suggesting expanded screening may boost detection, according to a real-world cohort study. Among 2 ...

Please provide your email address to receive an email when new articles are posted on . An updated clinical practice guideline suggested screening all people with hypertension for primary ...

Primary aldosteronism is often overlooked in hypertension. Educating providers and utilizing tools can enhance screening and treatment effectiveness, emphasizes Vivek Bhalla, MD, Stanford. Another ...

Aldosterone suppression testing is suggested where screening results indicate an intermediate probability for lateralizing PA and patients wish to pursue eligibility for surgical therapy. HealthDay ...

A collaborative study involving the University of Bristol and global partners has utilized a wearable device to uncover ...

For patients with obesity and primary aldosteronism, there is a link to a higher cardiometabolic burden and poorer clinical response to targeted treatments.

Diagnosis of aldosteronism is a 2-step process: the hormone imbalance must first be recognized and then differentiated as a primary or secondary condition. The Endocrine Society recommends measuring ...